Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.

NCT02100046 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Neuropathic Traumatic Pain
Pain NRS ≥ 4
Peripheral Neuropathic Pain
Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4

Interventions

DRUG: Zarontin® (ethosuximide) and Stodal®

Sponsor

University Hospital, Clermont-Ferrand

Collaborators

[object Object]